Risk Factors for Heart Failure with Preserved or Reduced Ejection Fraction Among Medicare Beneficiaries: Application of Competing Risks Analysis and Gradient Boosted Model

References

• Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation. 2018;137(12):e67–e492.29386200
   PubMed Web of Science ®Google Scholar
• Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol. 1993;22(4 Supplement 1):A6–A13. doi:10.1016/0735-1097(93)90455-A
   Web of Science ®Google Scholar
• Jessup M, Brozena S. Heart failure-reply. N Engl J Med. 2003;349(10):1004.
   Web of Science ®Google Scholar
• Komajda M, Lam CS. Heart failure with preserved ejection fraction: a clinical dilemma. Eur Heart J. 2014;35(16):1022–1032. doi:10.1093/eurheartj/ehu06724618346
   PubMed Web of Science ®Google Scholar
• Rose-Jones LJ, Rommel JJ, Chang PP. Heart failure with preserved ejection fraction: an ongoing enigma. Cardiol Clin. 2014;32(1):151–161. doi:10.1016/j.ccl.2013.09.00624286586
   PubMed Web of Science ®Google Scholar
• Paulus WJ, Tschöpe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62(4):263–271. doi:10.1016/j.jacc.2013.02.09223684677
   PubMed Web of Science ®Google Scholar
• Mahmood SS, Wang TJ. The epidemiology of congestive heart failure: contributions from the Framingham heart study. Glob Heart. 2013;8(1):77–82. doi:10.1016/j.gheart.2012.12.00623998000
   PubMedGoogle Scholar
• Chen YT, Vaccarino V, Williams CS, Butler J, Berkman LF, Krumholz HM. Risk factors for heart failure in the elderly: a prospective community-based study. Am J Med. 1999;106(6):605–612. doi:10.1016/S0002-9343(99)00126-610378616
   PubMed Web of Science ®Google Scholar
• Dunlay SM, Weston SA, Jacobsen SJ, Roger VL. Risk factors for heart failure: a population-based case-control study. Am J Med. 2009;122(11):1023–1028. doi:10.1016/j.amjmed.2009.04.02219854330
   PubMed Web of Science ®Google Scholar
• Ho JE, Lyass A, Lee DS, et al. Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction. Circ Heart Fail. 2013;6(2):279–286. doi:10.1161/CIRCHEARTFAILURE.112.97282823271790
   PubMed Web of Science ®Google Scholar
• Brouwers FP, de Boer RA, van der Harst P, et al. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur Heart J. 2013;34(19):1424–1431. doi:10.1093/eurheartj/eht06623470495
   PubMed Web of Science ®Google Scholar
• Cleland JG, Bunting KV, Flather MD, et al. Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials. Eur Heart J. 2017;39(1):26–35. doi:10.1093/eurheartj/ehx564
   Web of Science ®Google Scholar
• Emdin CA, Callender T, Cao J, McMurray JJ, Rahimi K. Meta-analysis of large-scale randomized trials to determine the effectiveness of inhibition of the renin-angiotensin aldosterone system in heart failure. Am J Cardiol. 2015;116(1):155–161. doi:10.1016/j.amjcard.2015.03.05225937349
   PubMed Web of Science ®Google Scholar
• Samson R, Jaiswal A, Ennezat PV, Cassidy M, Le Jemtel TH. Clinical phenotypes in heart failure with preserved ejection fraction. J Am Heart Assoc. 2016;5(1):e002477. doi:10.1161/JAHA.115.00247726811159
   PubMed Web of Science ®Google Scholar
• Tsao CW, Lyass A, Larson MG, Vasan RS. Divergent temporal trends in the incidence of heart failure with preserved and reduced ejection fraction. Circulation. 2015;131(suppl_1):A23.
   Google Scholar
• Steinberg BA, Zhao X, Heidenreich PA, et al. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction-prevalence, therapies, and outcomes. Circulation. 2012;126(1):65–75. doi:10.1161/CIRCULATIONAHA.111.08077022615345
   PubMed Web of Science ®Google Scholar
• Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355(3):251–259. doi:10.1056/NEJMoa05225616855265
   PubMed Web of Science ®Google Scholar
• Lee DS, Gona P, Vasan RS, et al. Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute. Circulation. 2009;119(24):3070–3077. doi:10.1161/CIRCULATIONAHA.108.81594419506115
   PubMed Web of Science ®Google Scholar
• Lunn M, McNeil D. Applying cox regression to competing risks. Biometrics. 1995;51(2):524–532. doi:10.2307/25329407662841
   PubMed Web of Science ®Google Scholar
• Lin KJ, Singer DE, Glynn RJ, Murphy SN, Lii J, Schneeweiss S. Identifying patients with high data completeness to improve validity of comparative effectiveness research in electronic health records data. Clin Pharmacol Ther. 2018;103(5):899–905. doi:10.1002/cpt.86128865143
   PubMed Web of Science ®Google Scholar
• Zhou L, Plasek JM, Mahoney LM, et al. Using Medical Text Extraction, Reasoning and Mapping System (MTERMS) to process medication information in outpatient clinical notes. AMIA Annu Symp Proc. 2011;2011:1639–1648.22195230
   PubMedGoogle Scholar
• Solomon SD, Claggett B, Lewis EF, et al. Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction. Eur Heart J. 2016;37(5):455–462. doi:10.1093/eurheartj/ehv46426374849
   PubMed Web of Science ®Google Scholar
• Senni M, Paulus WJ, Gavazzi A, et al. New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes. Eur Heart J. 2014;35(40):2797–2815. doi:10.1093/eurheartj/ehu20425104786
   PubMed Web of Science ®Google Scholar
• Lau B, Cole SR, Gange SJ. Competing risk regression models for epidemiologic data. Am J Epidemiol. 2009;170(2):244–256. doi:10.1093/aje/kwp10719494242
   PubMed Web of Science ®Google Scholar
• Friedman JH. Greedy function approximation: a gradient boosting machine. Ann Stat. 2001;1189–1232. doi:10.1214/aos/1013203451
   Web of Science ®Google Scholar
• Ridgeway G. GBM: generalized boosted regression models. R package vers. 2006;1(3):55.
   Google Scholar
• Friedman J, Hastie T, Tibshirani R. The Elements of Statistical Learning. Vol. 1 New York, NY, USA: Springer series in statistics; 2001.
   Google Scholar
• Harrell FE Jr., Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361–387. doi:10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-48668867
   PubMed Web of Science ®Google Scholar
• Pencina MJ, D’Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med. 2004;23(13):2109–2123. doi:10.1002/sim.180215211606
   PubMed Web of Science ®Google Scholar
• Borlaug BA, Redfield MM. Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum response to borlaug and redfield. Circulation. 2011;123(18):2006–2014. doi:10.1161/CIRCULATIONAHA.110.95438821555723
   PubMed Web of Science ®Google Scholar
• de Boer RA, Nayor M, deFilippi CR, et al. Association of cardiovascular biomarkers with incident heart failure with preserved and reduced ejection fraction. JAMA cardiol. 2018;3(3):215–224. doi:10.1001/jamacardio.2017.498729322198
   PubMed Web of Science ®Google Scholar
• Kotecha D, Lam CS, Van Veldhuisen DJ, Van Gelder IC, Voors AA, Rienstra M. Heart failure with preserved ejection fraction and atrial fibrillation: vicious twins. J Am Coll Cardiol. 2016;68(20):2217–2228. doi:10.1016/j.jacc.2016.08.04827855811
   PubMed Web of Science ®Google Scholar
• Lam CS, Roger VL, Rodeheffer RJ, Borlaug BA, Enders FT, Redfield MM. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol. 2009;53(13):1119–1126. doi:10.1016/j.jacc.2008.11.05119324256
   PubMed Web of Science ®Google Scholar
• Dunlay SM, Roger VL, Redfield MM. Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2017;14(10):591–602. doi:10.1038/nrcardio.2017.6528492288
   PubMed Web of Science ®Google Scholar
• Poppe KK, Squire IB, Whalley GA, et al. Known and missing left ventricular ejection fraction and survival in patients with heart failure: a MAGGIC meta-analysis report. Eur J Heart Fail. 2013;15(11):1220–1227. doi:10.1093/eurjhf/hft10123803952
   PubMed Web of Science ®Google Scholar
• Munoz MA, Mundet-Tuduri X, Real J, et al. Heart failure labelled patients with missing ejection fraction in primary care: prognosis and determinants. BMC Fam Pract. 2017;18(1):38. doi:10.1186/s12875-017-0612-628302060
   PubMed Web of Science ®Google Scholar
• Jollis JG, Ancukiewicz M, DeLong ER, Pryor DB, Muhlbaier LH, Mark DB. Discordance of databases designed for claims payment versus clinical information systems: implications for outcomes research. Ann Intern Med. 1993;119(8):844–850. doi:10.7326/0003-4819-119-8-199310150-000118018127
   PubMed Web of Science ®Google Scholar